<DOC>
	<DOCNO>NCT02560207</DOCNO>
	<brief_summary>This study evaluate target attainment either intermittent intravenous bolus intravenous continuous infusion cefotaxime critically ill patient . Critically ill patient randomize intermittent infusion continuous infusion cefotaxime .</brief_summary>
	<brief_title>Randomized Trial Continuous Versus Intermittent Cefotaxime Infusion ICU .</brief_title>
	<detailed_description>Critically ill patient pharmacokinetic/pharmacodynamic profile healthy volunteer . Suboptimal , under- overdose antibiotic important threat patient category . Given time-dependent character beta-lactam antibiotic continuous dose opposed traditional intermittent dose likely render well target attainment maintenance might improve clinical outcome .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Cefotaxime</mesh_term>
	<mesh_term>Cefoxitin</mesh_term>
	<criteria>Admitted intensive care Able give inform consent inform consent obtain via next kin Indication treatment cefotaxime ( judged treat physician ) context standard treatment protocol Selective decontamination digestive tract ( SDD ) . Renal replacement therapy Contraindication cefotaxime , include know suspected allergy cefotaxime No indication arterial line ; arterial line place solely purpose study ; thus , patient indication arterial line outside protocol eligible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>